|
1
|
A laboratory comparison of T cell depletion by CD34+ cell immunoaffinity selection and in vitro Campath-1M treatment: clinical implications for bone marrow transplantation and donor leukocyte therapy.
|
Bone Marrow Transplant
|
1997
|
1.96
|
|
2
|
Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis.
|
Br J Haematol
|
1999
|
1.13
|
|
3
|
Transient erythroblastopenia of childhood with CD10, TdT, and cytoplasmic mu lymphocyte positivity in bone marrow.
|
J Clin Pathol
|
1990
|
1.08
|
|
4
|
Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation.
|
Bone Marrow Transplant
|
1998
|
0.92
|
|
5
|
Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant.
|
Br J Haematol
|
2001
|
0.92
|
|
6
|
An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality.
|
Bone Marrow Transplant
|
2009
|
0.92
|
|
7
|
A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia.
|
Blood
|
1994
|
0.87
|
|
8
|
Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (+/- fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion.
|
Cytotherapy
|
2001
|
0.86
|
|
9
|
The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study.
|
Bone Marrow Transplant
|
2011
|
0.86
|
|
10
|
Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission.
|
Br J Haematol
|
1996
|
0.85
|
|
11
|
Unrelated donor bone marrow transplantation in children and young adults with acute myeloid leukaemia in remission.
|
Br J Haematol
|
1997
|
0.84
|
|
12
|
Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation.
|
Tissue Antigens
|
2004
|
0.84
|
|
13
|
Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy.
|
Gene Ther
|
2002
|
0.84
|
|
14
|
Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia.
|
Br J Haematol
|
1998
|
0.83
|
|
15
|
An analysis of the effect of chronic GvHD on relapse and survival following allogeneic PBSC transplantation.
|
Cytotherapy
|
2000
|
0.83
|
|
16
|
Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD.
|
Bone Marrow Transplant
|
2011
|
0.82
|
|
17
|
Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy.
|
J Antimicrob Chemother
|
1990
|
0.82
|
|
18
|
The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation.
|
Bone Marrow Transplant
|
2003
|
0.82
|
|
19
|
Immune reconstitution after BMT in children.
|
Bone Marrow Transplant
|
1993
|
0.81
|
|
20
|
Novel approaches to transplant conditioning.
|
Hematol Oncol
|
2001
|
0.81
|
|
21
|
Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia.
|
Br J Haematol
|
1998
|
0.80
|
|
22
|
The use of a national transplant registry to benchmark transplant outcome for patients undergoing autologous and allogeneic stem cell transplantation in the United Kingdom and Ireland.
|
Br J Haematol
|
2004
|
0.80
|
|
23
|
Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms.
|
Bone Marrow Transplant
|
2009
|
0.78
|
|
24
|
Third complementarity determining region (CDR III) sequence analysis in childhood B-lineage acute lymphoblastic leukaemia: implications for the design of oligonucleotide probes for use in monitoring minimal residual disease.
|
Leukemia
|
1992
|
0.78
|
|
25
|
A dedicated GvHD clinic may improve the quality of life for allogeneic stem cell transplant survivors.
|
Clin Transplant
|
2012
|
0.77
|
|
26
|
Bone marrow transplantation from volunteer unrelated donors.
|
Cancer Treat Rev
|
1995
|
0.77
|
|
27
|
Mycophenolic acid trough level monitoring: relevance in acute and chronic graft versus host disease and its relation with albumin.
|
Clin Transplant
|
2011
|
0.77
|
|
28
|
Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study.
|
Bone Marrow Transplant
|
2013
|
0.77
|
|
29
|
Eosinophilic leukaemia with an abnormality of 5q31, the site of the IL-5 gene.
|
Clin Lab Haematol
|
1991
|
0.77
|
|
30
|
Matched and mismatched unrelated donor bone marrow transplantation for juvenile chronic myeloid leukaemia.
|
Br J Haematol
|
1996
|
0.77
|
|
31
|
Comparison of fluorescent consensus IgH PCR and allele-specific oligonucleotide probing in the detection of minimal residual disease in childhood ALL.
|
Br J Haematol
|
1997
|
0.77
|
|
32
|
The study of minimal residual disease in acute lymphoblastic leukaemia.
|
Clin Mol Pathol
|
1995
|
0.77
|
|
33
|
The use of the polymerase chain reaction to detect minimal residual disease in childhood acute lymphoblastic leukaemia.
|
Eur J Cancer
|
1993
|
0.76
|
|
34
|
Faster engraftment of peripheral blood progenitor cells compared to bone marrow from unrelated donors.
|
Bone Marrow Transplant
|
1998
|
0.76
|
|
35
|
Aspergillus appendicitis in acute myeloid leukaemia.
|
Clin Lab Haematol
|
1990
|
0.76
|
|
36
|
Clonal instability in early B-lineage acute lymphoblastic leukemia.
|
Blood
|
1992
|
0.75
|
|
37
|
Effects of haemopoietic growth factors for aplastic anaemia.
|
Lancet
|
1994
|
0.75
|
|
38
|
Double T cell depletion of bone marrow using sequential positive and negative cell immunoaffinity or CD34+ cell selection followed by Campath-1M; effect on CD34+ cells and progenitor cell recoveries.
|
Bone Marrow Transplant
|
1998
|
0.75
|
|
39
|
Transplantation of peripheral blood progenitor cells from unrelated donors.
|
Bone Marrow Transplant
|
1996
|
0.75
|
|
40
|
Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukaemia of precursor B-cell origin.
|
Leukemia
|
1992
|
0.75
|
|
41
|
The role of plasma exchange for TTP/HUS post-bone marrow transplant.
|
Bone Marrow Transplant
|
1996
|
0.75
|
|
42
|
Solid-phase sequencing of multiple PCR products resolved by polyacrylamide gel electrophoresis.
|
Biotechniques
|
1995
|
0.75
|
|
43
|
Same-day determination of chimaeric status in the immediate period following allogeneic bone marrow transplantation.
|
Br J Haematol
|
1997
|
0.75
|
|
44
|
Unrelated donor bone marrow transplant in childhood ALL. The role of T-cell depletion.
|
Bone Marrow Transplant
|
1996
|
0.75
|
|
45
|
Granulocyte-macrophage colony-stimulating factor (GM-CSF), hypocalcemia, and hypomagnesemia.
|
Ann Intern Med
|
1990
|
0.75
|
|
46
|
False-positive residual disease assessment after bone marrow transplant in acute lymphoblastic leukemia.
|
Blood
|
1994
|
0.75
|